Intellia Therapeutics Inc (NTLA) Rapporto sugli Utili - Previsioni e Surprise Ratio

Pubblicita'

Storico dei ricavi trimestrali

NTLA rapporto: 44%

100%

NTLA supera 15 di 34 ultime stime

Data del prossimo reportNov 14, 2024

Stimato per Q4 24:$-1.32

Cambiamenti implicati per il Q3 24:+0.76%

Cambiamenti implicati per il Q4 23:-4.35%

Periodo Bilanci	Data Riportata	EPS / Previsioni	Sorpresa
Q3 24	Nov 7, 2024	$-1.34 / $-1.37	$0.03 / 2.19%
Q2 24	Aug 8, 2024	$-1.31 / $-1.21	$-0.1 / -8.26%
Q1 24	May 9, 2024	$-1.06 / $-1.35	$0.29 / 21.48%
Q4 23	Feb 22, 2024	$-1.46 / $-1.47	$0.01 / 0.68%
Q3 23	Nov 9, 2023	$-1.38 / $-1.52	$0.14 / 9.21%
Q2 23	Aug 3, 2023	$-1.4 / $-1.32	$-0.08 / -6.06%
Q1 23	May 4, 2023	$-1.17 / $-1.41	$0.24 / 17.02%
Q4 22	Feb 23, 2023	$-1.4 / $-1.4	$0 / -

Fornitori di Dati: Xignite Logo